Evidence map›Paper›PMID 26199340›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2015

Racial and Ethnic Disparity in Symptomatic Breast Cancer Awareness despite a Recent Screen: The Role of Tumor Biology and Mammography Facility Characteristics.

Mylove Mortel, Garth H Rauscher, Anne Marie Murphy, Kent Hoskins, Richard B Warnecke

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Diagnostic Mammography Performance across Racial and Ethnic Groups in a National Network of Community-Based Breast Imaging Facilities.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  5. Article
  6. Atypical Chemokine Receptor 1 (Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019
    Article
  7. Multilevel Examination of Health Disparity: The Role of Policy Implementation in Neighborhood Context, in Patient Resources, and in Healthcare Facilities on Later Stage of Breast Cancer Diagnosis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2018
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mylove MortelDivision of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, Illinois.
Garth H RauscherDivision of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, Illinois. garthr@uic.edu.
Anne Marie MurphyMetropolitan Chicago Breast Cancer Task Force, Chicago, Illinois.
Kent HoskinsDepartment of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Richard B WarneckeInstitute for Health Research and Policy, University of Illinois at Chicago, Chicago, Illinois.
University of Illinois Chicago · USEqual Hope · US

Funding

Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Diana L Miglioretti · 2011 to 2026
$52.9M
UIC CENTERS FOR POPULATION HEALTH AND HEALTH DISPARITIESP50CA106743 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI WARNECKE, RICHARD · 2003 to 2016
$19.3M
Comparative effectiveness of breast imaging modalities: a natural experimentR01HS018366 · AHRQ · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAUSCHER, GARTH H · 2010 to 2014
$1.8M
AHRQ HHS 1-R01 HS018366-01A1AHRQ HHS R01 HS018366NCI NIH HHS 1P50CA106743NCI NIH HHS 2P50CA106743NCI NIH HHS P01 CA154292NCI NIH HHS P50 CA106743
6 · The paper itself

Abstract

backgroundIn a racially and ethnically diverse sample of recently diagnosed urban patients with breast cancer, we examined associations of patient, tumor biology, and mammography facility characteristics on the probability of symptomatic discovery of their breast cancer despite a recent prior screening mammogram.

methodsIn the Breast Cancer Care in Chicago study, self-reports at interview were used to define patients as having a screen-detected breast cancer or having symptomatic awareness despite a recent screening mammogram (SADRS), in the past 1 or 2 years. Patients with symptomatic breast cancer who did not report a recent prior screen were excluded from these analyses. Characteristics associated with more aggressive disease [estrogen receptor (ER)- and progesterone receptor (PR)-negative status and higher tumor grade] were abstracted from medical records. Mammogram facility characteristics that might indicate aspects of screening quality were defined and controlled for in some analyses.

resultsSADRS was more common among non-Hispanic black and Hispanic than among non-Hispanic white patients (36% and 42% vs. 25%, respectively, P = 0.0004). SADRS was associated with ER/PR-negative and higher-grade disease. Patients screened at sites that relied on dedicated radiologists and sites that were breast imaging centers of excellence were less likely to report SADRS. Tumor and facility factors together accounted for two thirds of the disparity in SADRS (proportion mediated = 70%, P = 0.02).

conclusionFacility resources and tumor aggressiveness explain much of the racial/ethnic disparity in symptomatic breast cancer among recently screened patients. IMPACT: A more equitable distribution of high-quality screening would ameliorate but not eliminate this disparity.

Indexed as

AwarenessCancer Care FacilitiesEthnicityMammographyRacial GroupsAdultAgedBreast NeoplasmsChicagoEarly Detection of CancerFemaleFollow-Up StudiesHumansIncidenceMiddle AgedPrognosis

Identifiers

PMID26199340
PMCPMC4592461
OpenAlexW2200488218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.